Osmotically dehydrated and air dried berry fruits are used as elements for the manufacturing of yoghurts, goodies, cereal bars and mixes, ice lotions and desserts and these fruits are sometimes subjected to gentle thermal therapies solely, posing questions round their microbiological security.
As osmotic dehydration strategies and parameters range significantly throughout the trade and minimally processed top quality fruits are more and more sought, the scope of this research was to find out which temperatures are required for the inactivation of related micro organism and viruses throughout osmotic dehydration of berries, utilizing blueberries as a mannequin berry in a thawed state to imitate frequent industrial practices.
Moreover, we studied the inactivation of osmotic dehydration at 23 °C, generally referred to “chilly infusion” adopted by air drying at 100 °C to find out the microbiological security achieved by this mixed remedy. 4 pathogens (Salmonella enterica, Escherichia coli O157:
H7, Listeria monocytogenes and hepatitis A virus (HAV)) and 5 surrogates (Enterococcus faecium, Escherichia coli P1, Listeria innocua, murine Norovirus (MNV) and bacteriophage MS2) had been inoculated on blueberries and reductions had been measured after totally different remedy mixtures. After osmotic dehydration of bacterial strains at 40 °C no survivors had been detected on blueberries, apart from E. faecium.
Inactivation of the viruses at 45 °C confirmed no survivors for MS2 and imply reductions of 1.5 and three.four log10 median tissue tradition infectious dose (TCID50)/g for HAV and MNV, respectively. Equally, within the sugar resolution at 40 °C, no survivors had been noticed, apart from E. faecium and the three viruses. The mixed course of (osmotic dehydration at 23 °C adopted by air-drying at 100 °C) achieved an >6 log discount of all examined bacterial strains and MS2.
EIF3K Antibody |
1-CSB-PA866204ESR1HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against EIF3K. Recognizes EIF3K from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IP; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200, IP:1:200-1:2000 |
EIF3K Antibody |
CSB-PA693741- |
Cusabio |
|
EUR 402 |
|
Description: A polyclonal antibody against EIF3K. Recognizes EIF3K from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000 |
EIF3K Antibody |
CSB-PA693741-100ul |
Cusabio |
100ul |
EUR 379.2 |
|
Description: A polyclonal antibody against EIF3K. Recognizes EIF3K from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000 |
EIF3K antibody |
70R-36346 |
Fitzgerald |
100 ug |
EUR 392.4 |
Description: Rabbit polyclonal EIF3K antibody |
EIF3K antibody |
70R-12634 |
Fitzgerald |
100 ul |
EUR 548.4 |
Description: Affinity purified Rabbit polyclonal EIF3K antibody |
EIF3K Antibody |
34680-100ul |
SAB |
100ul |
EUR 302.4 |
EIF3K Antibody |
34680-50ul |
SAB |
50ul |
EUR 224.4 |
eIF3K antibody |
22622-100ul |
SAB |
100ul |
EUR 468 |
EIF3K siRNA |
20-abx915183 |
Abbexa |
|
|
|
EIF3K siRNA |
20-abx915184 |
Abbexa |
|
|
|
eIF3K Polyclonal Antibody |
ABP51246-003ml |
Abbkine |
0.03ml |
EUR 189.6 |
|
Description: A polyclonal antibody for detection of eIF3K from Human, Mouse. This eIF3K antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human eIF3K at AA range: 30-110 |
eIF3K Polyclonal Antibody |
ABP51246-01ml |
Abbkine |
0.1ml |
EUR 346.8 |
|
Description: A polyclonal antibody for detection of eIF3K from Human, Mouse. This eIF3K antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human eIF3K at AA range: 30-110 |
eIF3K Polyclonal Antibody |
ABP51246-02ml |
Abbkine |
0.2ml |
EUR 496.8 |
|
Description: A polyclonal antibody for detection of eIF3K from Human, Mouse. This eIF3K antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human eIF3K at AA range: 30-110 |
EIF3K Blocking Peptide |
DF4052-BP |
Affbiotech |
1mg |
EUR 234 |
EIF3K Conjugated Antibody |
C34680 |
SAB |
100ul |
EUR 476.4 |
EIF3K cloning plasmid |
CSB-CL866204HU-10ug |
Cusabio |
10ug |
EUR 279.6 |
|
Description: A cloning plasmid for the EIF3K gene. |
anti- EIF3K antibody |
FNab02712 |
FN Test |
100µg |
EUR 658.5 |
|
Description: Antibody raised against EIF3K |
eIF3K Polyclonal Antibody |
ES2245-100ul |
ELK Biotech |
100ul |
EUR 334.8 |
Description: A Rabbit Polyclonal antibody against eIF3K from Human/Mouse. This antibody is tested and validated for WB, ELISA, WB, ELISA |
eIF3K Polyclonal Antibody |
ES2245-50ul |
ELK Biotech |
50ul |
EUR 248.4 |
Description: A Rabbit Polyclonal antibody against eIF3K from Human/Mouse. This antibody is tested and validated for WB, ELISA, WB, ELISA |
Anti-EIF3K Antibody |
A07789 |
BosterBio |
100ul |
EUR 476.4 |
Description: Rabbit Polyclonal Antibody for EIF3K (EIF3K) detection. Tested with WB in Human. |
Anti-eIF3K Antibody |
A07789-1 |
BosterBio |
100ul |
EUR 476.4 |
Description: Rabbit Polyclonal Antibody for eIF3K Antibody (EIF3K) detection. Tested with WB in Human, Mouse. |
Anti-EIF3K Antibody |
A30681 |
BosterBio |
100ul |
EUR 476.4 |
Description: Rabbit Polyclonal EIF3K Antibody. Validated in WB and tested in Human, Mouse. |
EIF3K Blocking Peptide |
20-abx161607 |
Abbexa |
|
|
|
EIF3K Rabbit pAb |
A9969-100ul |
Abclonal |
100 ul |
EUR 369.6 |
EIF3K Rabbit pAb |
A9969-200ul |
Abclonal |
200 ul |
EUR 550.8 |
EIF3K Rabbit pAb |
A9969-20ul |
Abclonal |
20 ul |
EUR 219.6 |
EIF3K Rabbit pAb |
A9969-50ul |
Abclonal |
50 ul |
EUR 267.6 |
Anti-eIF3K antibody |
STJ92875 |
St John's Laboratory |
200 µl |
EUR 236.4 |
Description: Rabbit polyclonal to eIF3K. |
Human EIF3K shRNA Plasmid |
20-abx959085 |
Abbexa |
|
|
|
Mouse EIF3K shRNA Plasmid |
20-abx978028 |
Abbexa |
|
|
|
EIF3K protein (His tag) |
80R-1730 |
Fitzgerald |
50 ug |
EUR 366 |
Description: Purified recombinant Human EIF3K protein |
eIF3k Recombinant Protein (Mouse) |
RP131297 |
ABM |
100 ug |
Ask for price |
eIF3k Recombinant Protein (Rat) |
RP199370 |
ABM |
100 ug |
Ask for price |
eIF3k Recombinant Protein (Human) |
RP010423 |
ABM |
100 ug |
Ask for price |
Polyclonal EIF3K Antibody (C-term) |
AMM05865G |
Leading Biology |
0.1ml |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human EIF3K (C-term). This antibody is tested and proven to work in the following applications: |
Eif3k ORF Vector (Rat) (pORF) |
ORF066458 |
ABM |
1.0 ug DNA |
EUR 607.2 |
EIF3K ORF Vector (Human) (pORF) |
ORF003475 |
ABM |
1.0 ug DNA |
EUR 114 |
Eif3k ORF Vector (Mouse) (pORF) |
ORF043767 |
ABM |
1.0 ug DNA |
EUR 607.2 |
EIF3K sgRNA CRISPR Lentivector set (Human) |
K0668501 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
Eif3k sgRNA CRISPR Lentivector set (Rat) |
K6347101 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
Eif3k sgRNA CRISPR Lentivector set (Mouse) |
K4858401 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
EIF3K sgRNA CRISPR Lentivector (Human) (Target 1) |
K0668502 |
ABM |
1.0 ug DNA |
EUR 184.8 |
EIF3K sgRNA CRISPR Lentivector (Human) (Target 2) |
K0668503 |
ABM |
1.0 ug DNA |
EUR 184.8 |
EIF3K sgRNA CRISPR Lentivector (Human) (Target 3) |
K0668504 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Eif3k sgRNA CRISPR Lentivector (Rat) (Target 1) |
K6347102 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Eif3k sgRNA CRISPR Lentivector (Rat) (Target 2) |
K6347103 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Eif3k sgRNA CRISPR Lentivector (Rat) (Target 3) |
K6347104 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Eif3k sgRNA CRISPR Lentivector (Mouse) (Target 1) |
K4858402 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Eif3k sgRNA CRISPR Lentivector (Mouse) (Target 2) |
K4858403 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Eif3k sgRNA CRISPR Lentivector (Mouse) (Target 3) |
K4858404 |
ABM |
1.0 ug DNA |
EUR 184.8 |
eIF3k Protein Vector (Human) (pPB-C-His) |
PV013897 |
ABM |
500 ng |
EUR 394.8 |
eIF3k Protein Vector (Human) (pPB-N-His) |
PV013898 |
ABM |
500 ng |
EUR 394.8 |
eIF3k Protein Vector (Human) (pPM-C-HA) |
PV013899 |
ABM |
500 ng |
EUR 394.8 |
eIF3k Protein Vector (Human) (pPM-C-His) |
PV013900 |
ABM |
500 ng |
EUR 394.8 |
eIF3k Protein Vector (Mouse) (pPB-C-His) |
PV175066 |
ABM |
500 ng |
EUR 723.6 |
eIF3k Protein Vector (Mouse) (pPB-N-His) |
PV175067 |
ABM |
500 ng |
EUR 723.6 |
eIF3k Protein Vector (Mouse) (pPM-C-HA) |
PV175068 |
ABM |
500 ng |
EUR 723.6 |
eIF3k Protein Vector (Mouse) (pPM-C-His) |
PV175069 |
ABM |
500 ng |
EUR 723.6 |
Recombinant Human EIF3K Protein, His, E.coli-10ug |
QP11769-10ug |
EnQuireBio |
10ug |
EUR 241.2 |
Recombinant Human EIF3K Protein, His, E.coli-1mg |
QP11769-1mg |
EnQuireBio |
1mg |
EUR 6301.2 |
Recombinant Human EIF3K Protein, His, E.coli-2ug |
QP11769-2ug |
EnQuireBio |
2ug |
EUR 186 |
eIF3k Protein Vector (Rat) (pPB-C-His) |
PV265830 |
ABM |
500 ng |
EUR 723.6 |
eIF3k Protein Vector (Rat) (pPB-N-His) |
PV265831 |
ABM |
500 ng |
EUR 723.6 |
eIF3k Protein Vector (Rat) (pPM-C-HA) |
PV265832 |
ABM |
500 ng |
EUR 723.6 |
eIF3k Protein Vector (Rat) (pPM-C-His) |
PV265833 |
ABM |
500 ng |
EUR 723.6 |
EIF3K 3'UTR Luciferase Stable Cell Line |
TU006747 |
ABM |
1.0 ml |
EUR 1672.8 |
Eif3k 3'UTR Luciferase Stable Cell Line |
TU203890 |
ABM |
1.0 ml |
Ask for price |
Eif3k 3'UTR GFP Stable Cell Line |
TU253890 |
ABM |
1.0 ml |
Ask for price |
Eif3k 3'UTR GFP Stable Cell Line |
TU155723 |
ABM |
1.0 ml |
Ask for price |
Eif3k 3'UTR Luciferase Stable Cell Line |
TU105723 |
ABM |
1.0 ml |
Ask for price |
EIF3K 3'UTR GFP Stable Cell Line |
TU056747 |
ABM |
1.0 ml |
EUR 1672.8 |
Human Eukaryotic translation initiation factor 3 subunit K (EIF3K) |
1-CSB-EP866204HU |
Cusabio |
-
EUR 733.20
-
EUR 370.80
-
EUR 2192.40
-
EUR 1126.80
-
EUR 1461.60
-
EUR 476.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Human Eukaryotic translation initiation factor 3 subunit K(EIF3K) expressed in E.coli |
Eukaryotic Translation Initiation Factor 3 Subunit K (EIF3K) Antibody |
20-abx121897 |
Abbexa |
-
EUR 360.00
-
EUR 526.80
-
EUR 226.80
|
|
|
Eukaryotic Translation Initiation Factor 3 Subunit K (EIF3K) Antibody |
abx122816-100ug |
Abbexa |
100 ug |
EUR 469.2 |
|
Eukaryotic Translation Initiation Factor 3 Subunit K (EIF3K) Antibody |
20-abx135889 |
Abbexa |
-
EUR 493.20
-
EUR 710.40
-
EUR 218.40
-
EUR 376.80
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
Eukaryotic Translation Initiation Factor 3 Subunit K (EIF3K) Antibody |
20-abx014467 |
Abbexa |
-
EUR 376.80
-
EUR 117.60
-
EUR 477.60
-
EUR 594.00
|
- 100 ug
- 10 ug
- 200 ug
- 300 µg
|
|
Eukaryotic Translation Initiation Factor 3 Subunit K (EIF3K) Antibody |
abx029064-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
Eukaryotic Translation Initiation Factor 3 Subunit K (EIF3K) Antibody |
abx029064-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
Eukaryotic Translation Initiation Factor 3 Subunit K (EIF3K) Antibody |
abx232712-100ug |
Abbexa |
100 ug |
EUR 610.8 |
|
Eukaryotic Translation Initiation Factor 3 Subunit K (EIF3K) Antibody |
abx330943-100ul |
Abbexa |
100 ul |
EUR 510 |
|
Eukaryotic Translation Initiation Factor 3 Subunit K (EIF3K) Antibody |
20-abx321399 |
Abbexa |
|
|
|
Eukaryotic Translation Initiation Factor 3 Subunit K (EIF3K) Antibody |
20-abx325584 |
Abbexa |
|
|
|
EIF3K Eukaryotic Translation Initiation Factor 3K Human Recombinant Protein |
PROTQ9UBQ5 |
BosterBio |
Regular: 10ug |
EUR 380.4 |
Description: EIF3K produced in E.Coli is a single, non-glycosylated polypeptide chain containing 238 amino acids (1-218a.a.) and having a molecular mass of 27.2 kDa. ;EIF3K is fused to a 20 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
Recombinant Aspergillus Clavatus EIF3K Protein (aa 1-249) [His] |
VAng-Wyb3769-1mg |
Creative Biolabs |
1 mg |
EUR 5046 |
Description: Aspergillus Clavatus (strain ATCC 1007 / CBS 513.65 / DSM 816 / NCTC 3887 / NRRL 1) Eukaryotic Translation Initiation Factor 3 Subunit K, recombinant protein. |
EIF3K sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
K0668505 |
ABM |
3 x 1.0 ug |
EUR 451.2 |
Eif3k sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) |
K6347105 |
ABM |
3 x 1.0 ug |
EUR 451.2 |
Eif3k sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
K4858405 |
ABM |
3 x 1.0 ug |
EUR 451.2 |
Human Eukaryotic Translation Initiation Factor 3 Subunit K (EIF3K) ELISA Kit |
abx387100-96tests |
Abbexa |
96 tests |
EUR 1093.2 |
|
EIF3K sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
K0668506 |
ABM |
1.0 ug DNA |
EUR 200.4 |
EIF3K sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
K0668507 |
ABM |
1.0 ug DNA |
EUR 200.4 |
EIF3K sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
K0668508 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Eif3k sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1) |
K6347106 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Eif3k sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2) |
K6347107 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Eif3k sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3) |
K6347108 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Eif3k sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
K4858406 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Eif3k sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
K4858407 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Eif3k sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
K4858408 |
ABM |
1.0 ug DNA |
EUR 200.4 |
For HAV and MNV, 2.6 and >3.four log10 TCID50/g had been measured. In abstract, the current research exhibits that osmotic dehydration seems an environment friendly management measure for the management of L. monocytogenes, S. enterica and E. coli O157:H7 if carried out at 40 °C or at 23 °C and adopted by air-drying at 100 °C. Primarily based on the outcomes generated with MNV, the mixed remedy can also be anticipated to scale back human Norovirus (NoV) however doesn’t seem like adequate to totally management HAV.
The outcomes contribute to a greater administration of the microbial security of osmotically dehydrated and dried berries and particularly the outcomes generated for the viruses emphasize that inside a strong meals security administration system, security have to be assured via the complete meals provide chain and due to this fact should begin at main manufacturing with the implementation of Good Agricultural Practices (GAP).